KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomnia Symptoms
A phase 2 trial found KP1077 provides clinically meaningful benefits for idiopathic hypersomnia.
United States Christopher Drake Henry Ford Health Christopher Drake American Academy Of Sleep Medicine Drug Administration Us Drug Enforcement Agency
Source: hcplive.com